Cost-effectiveness of 13-valent pneumococcal conjugate vaccination in Mongolia

OBJECTIVE: The Ministry of Health (MOH), Mongolia, is considering introducing 13-valent pneumococcal conjugate vaccine (PCV13) in its national immunization programme to prevent the burden of disease caused by Streptococcus pneumoniae. This study evaluates the cost-effectiveness and budget impact of...

Descripción completa

Detalles Bibliográficos
Autores principales: Sundaram, Neisha, Chen, Cynthia, Yoong, Joanne, Luvsan, Munkh-Erdene, Fox, Kimberley, Sarankhuu, Amarzaya, La Vincente, Sophie, Jit, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5297341/
https://www.ncbi.nlm.nih.gov/pubmed/28109706
http://dx.doi.org/10.1016/j.vaccine.2016.12.070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5297341/
https://www.ncbi.nlm.nih.gov/pubmed/28109706
http://dx.doi.org/10.1016/j.vaccine.2016.12.070

Ejemplares similares